home / stock / alny / alny short
Short Information | Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,864,218 |
Total Actual Volume | 9,989,915 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 93,211 |
Average Short Percentage | 18.89% |
Is there a ALNY Short Squeeze or Breakout about to happen?
See the ALNY Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-24-2024 | $146.6 | $143.8 | $147.486 | $143.52 | 388,114 | 100,800 | 25.97% |
04-23-2024 | $147.35 | $146.07 | $150.27 | $145.04 | 542,714 | 85,574 | 15.77% |
04-22-2024 | $145.21 | $145.79 | $147.9 | $143.6911 | 399,984 | 64,061 | 16.02% |
04-19-2024 | $144.72 | $144.41 | $146.92 | $143.5 | 703,168 | 98,706 | 14.04% |
04-18-2024 | $145 | $145.16 | $146.47 | $144.23 | 398,914 | 94,457 | 23.68% |
04-17-2024 | $146.7 | $145.32 | $147.49 | $145.19 | 601,282 | 68,778 | 11.44% |
04-16-2024 | $146.37 | $146.72 | $148.44 | $146.01 | 352,430 | 76,708 | 21.77% |
04-15-2024 | $148.62 | $147.7 | $150.37 | $146.73 | 498,939 | 80,033 | 16.04% |
04-12-2024 | $151.8 | $148.5 | $151.8 | $148.28 | 428,052 | 75,536 | 17.65% |
04-11-2024 | $154.02 | $152.09 | $154.02 | $149.93 | 473,419 | 68,121 | 14.39% |
04-10-2024 | $154.89 | $152.41 | $154.955 | $151.91 | 571,403 | 101,554 | 17.77% |
04-09-2024 | $157.26 | $155.9 | $159.34 | $154.89 | 595,961 | 105,972 | 17.78% |
04-08-2024 | $154.63 | $156.04 | $157.96 | $153.25 | 738,226 | 201,393 | 27.28% |
04-05-2024 | $150.15 | $153.56 | $154 | $149.4079 | 351,493 | 69,157 | 19.68% |
04-04-2024 | $151 | $151.48 | $154.38 | $150.8 | 531,883 | 127,657 | 24% |
04-03-2024 | $150.19 | $150.83 | $151.27 | $149.25 | 315,208 | 62,485 | 19.82% |
04-02-2024 | $151.89 | $151.04 | $152.27 | $150.67 | 445,840 | 78,316 | 17.57% |
04-01-2024 | $148.57 | $153.33 | $154.21 | $147.58 | 523,250 | 124,330 | 23.76% |
03-28-2024 | $154.48 | $149.45 | $154.5 | $149.32 | 666,592 | 85,741 | 12.86% |
03-27-2024 | $152.83 | $154.39 | $155.28 | $150.4 | 463,043 | 94,839 | 20.48% |
News, Short Squeeze, Breakout and More Instantly...
Alnylam Pharmaceuticals Inc. Company Name:
ALNY Stock Symbol:
NASDAQ Market:
Alnylam Pharmaceuticals Inc. Website:
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the first quarter ending March 31, 2024 on Thursday, May 2, 2024, before the U.S. financial markets open. Management will provide an update on the C...
On Sunday, Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) presented results from the KARDIA-2 Phase 2 study, which evaluated the efficacy and...
– Study Met Primary Endpoint Demonstrating Clinically Significant Additive Reductions in Ambulatory Systolic Blood Pressure of Up to 12.1 mmHg Across Three Independent Study Cohorts at Month 3 – – A Single Dose of Zilebesiran Resulted in Clinically Significant Additiv...